5 Results for "

Maytansinoid B

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Maytansinoid B" in MCE Product Catalog:

Cat. No.: HY-148870
CAS No.: 1628543-40-7
Purity:  95.48%
Target:  

ADC Payloads

Research Areas:  

Cancer

Maytansinoid B is a kind of ADC Cytotoxin. Maytansinoid B can be used to conjugates with antibodies to form antibody-drug conjugates (ADCs). Maytansinoids are known as antimitotic agents, binding to tubulin and inhibiting microtubule assembly. Maytansinoids induces G2/M arrest in the cell cycle to induce apoptosis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-141607
CAS No.: 1238517-16-2
Purity:  99.09%
Synonyms: BT-062; nBT062-DM4

Research Areas:  

Cancer

Indatuximab ravtansine (BT-062) is an antibody-drug conjugate (ADC) based on a murine/human chimeric form of B-B4 (specific for CD138), linked to the maytansinoid agent DM4 by disulphide bonds. Indatuximab ravtansine shows anti-tumor activities .
loading...
    loading...
Cat. No.: HY-114256
CAS No.: 1610413-96-1
Target:  

PSMA

Research Areas:  

Cancer

EC1169 is a cytotoxic maytansinoid conjugate that specifically binds to prostate-specific membrane antigen (PSMA). EC1169 precisely delivers the maytansinoid B hydrazide payload to PSMA-positive cells to exert antitumor activity. EC1169 only inhibits the growth of PSMA-positive cells but has no effect on PSMA-negative cells, and enables complete recovery in mice bearing PSMA-positive tumors. EC1169 exhibits safety with no body weight loss or major organ damage induced. EC1169 is used in studies of prostate cancer and other PSMA-expressing malignancies .
loading...
    loading...
Cat. No.: HY-148528
CAS No.: 2226467-76-9
Purity:  98.16%
Target:  

Others

Research Areas:  

Cancer

SC-VC-PAB-N-Me-L-Ala-Maytansinol (compound B1) can be used to synthesis MCC-Maytansinoid A. SC-VC-PAB-N-Me-L-Ala-Maytansinol can be used as a control compound for the cancer research .
loading...
    loading...
Cat. No.: HY-W074975R
CAS No.: 14949-00-9
Synonyms: 5-Amino-1,3,4-thiadiazole-2-sulfonamide (Standard)
Research Areas:  

Cancer

CL 5343 (Standard) is the analytical standard of CL 5343. This product is intended for research and analytical applications. CL 5343 (5-Amino-1,3,4-thiadiazole-2-sulfonamide) is an inhibitor of human carbonic anhydrase B (HCA-B). CL 5343 can serve as a CA9 ligand to achieve the targeted delivery of maytansinoid to the cell membrane of SKRC52 renal cancer cells .
loading...
    loading...